Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions aspredictors of survival in surgically resected gastric cancer patients

Citation
Dt. Danesi et al., Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions aspredictors of survival in surgically resected gastric cancer patients, CYTOMETRY, 42(1), 2000, pp. 27-34
Citations number
48
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CYTOMETRY
ISSN journal
01964763 → ACNP
Volume
42
Issue
1
Year of publication
2000
Pages
27 - 34
Database
ISI
SICI code
0196-4763(20000215)42:1<27:FCDPPP>2.0.ZU;2-4
Abstract
In order to determine retrospectively the impact of some cytometric and imm unohistochemical parameters on the overall survival of gastric cancer patie nts treated:with surgery alone, paraffin-embedded tumor samples from 137 ga stric carcinoma patients undergoing curative resection from 1987-1993 were analyzed by flow cytometry (FCM) acid immunohistochemistry (p53, c-erbB-2, and PCNA expression). FCM-derived parameters were DNA ploidy and fraction o f S-phase cells (SPF), Multiple regression analysis was applied to determin e the prognostic significance of the conventional clinicopathologic finding s together with the flow cytometric and immunohistochemical parameters on o verall survival. When all parameters were entered simultaneously into the C ox regression model, stage and DMA ploidy (DIVA index >1.35) clearly emerge d as the only independent prognostic factors. When the stages were analysed separately, the independent prognostic factors resulted DNA ploidy in earl y stages (I-ll)and grading in stage IIIA tumors. For stage IIIB tumors, no independent prognostic factor was found. These results indicate that the DN A ploidy pattern is a valuable predictor of survival in curatively resected gastric cancer patients, especially when less advanced tumors are taken in to consideration. (C) 2000 Wiley-Liss, Inc.